Lipocine
LPCN
#10856
Rank
$13.35 M
Marketcap
$1.62
Share price
-2.41%
Change (1 day)
-47.91%
Change (1 year)

Operating Margin for Lipocine (LPCN)

Operating Margin as of October 2026 (TTM): -800.82%

According to Lipocine's latest financial reports and stock price the company's current Operating Margin is -800.82%. At the end of 2025 the company had an Operating Margin of -487.04%.

Operating Margin history for Lipocine from 2021 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-487.04%-603886.03%
20240.08%-100.01%
2023-573.57%-73.34%
2022-2,151.59%54659.6%
2021-3.93%
2019-7,883.60%189.42%
2018-2,723.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Seagen
SGEN
-30.69%-96.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
15.81%-101.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
-69.66%-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.